Shin Nippon Biomedical Laboratories Dividends and Buybacks
Dividend criteria checks 2/6
Shin Nippon Biomedical Laboratories is a dividend paying company with a current yield of 3.57% that is well covered by earnings. Next payment date is on 30th June, 2025 with an ex-dividend date of 28th March, 2025.
Key information
3.6%
Dividend yield
0.0006%
Buyback Yield
| Total Shareholder Yield | 3.6% |
| Future Dividend Yield | 4.4% |
| Dividend Growth | 39.7% |
| Next dividend pay date | 30 Jun 25 |
| Ex dividend date | 28 Mar 25 |
| Dividend per share | n/a |
| Payout ratio | 42% |
Recent dividend and buyback updates
Shin Nippon Biomedical Laboratories (TSE:2395) Has Affirmed Its Dividend Of ¥30.00
Mar 05
Shin Nippon Biomedical Laboratories (TSE:2395) Is Due To Pay A Dividend Of ¥30.00
Feb 10Shin Nippon Biomedical Laboratories (TSE:2395) Will Pay A Dividend Of ¥30.00
Jan 10Shin Nippon Biomedical Laboratories (TSE:2395) Will Pay A Dividend Of ¥30.00
Dec 19Shin Nippon Biomedical Laboratories (TSE:2395) Is Paying Out A Dividend Of ¥30.00
Dec 02Recent updates
There May Be Some Bright Spots In Shin Nippon Biomedical Laboratories' (TSE:2395) Earnings
May 15Investors Continue Waiting On Sidelines For Shin Nippon Biomedical Laboratories, Ltd. (TSE:2395)
Apr 28Estimating The Intrinsic Value Of Shin Nippon Biomedical Laboratories, Ltd. (TSE:2395)
Apr 04Shin Nippon Biomedical Laboratories (TSE:2395) Has Affirmed Its Dividend Of ¥30.00
Mar 05Shin Nippon Biomedical Laboratories (TSE:2395) Is Due To Pay A Dividend Of ¥30.00
Feb 10Shin Nippon Biomedical Laboratories (TSE:2395) Will Pay A Dividend Of ¥30.00
Jan 10Shin Nippon Biomedical Laboratories (TSE:2395) Will Pay A Dividend Of ¥30.00
Dec 19Shin Nippon Biomedical Laboratories (TSE:2395) Is Paying Out A Dividend Of ¥30.00
Dec 02What Shin Nippon Biomedical Laboratories, Ltd.'s (TSE:2395) 25% Share Price Gain Is Not Telling You
Nov 25Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00
Sep 19Earnings Miss: Shin Nippon Biomedical Laboratories, Ltd. Missed EPS By 88% And Analysts Are Revising Their Forecasts
Aug 09Little Excitement Around Shin Nippon Biomedical Laboratories, Ltd.'s (TSE:2395) Earnings As Shares Take 28% Pounding
Aug 06Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00
Jul 26Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00
Jul 12Shin Nippon Biomedical Laboratories' (TSE:2395) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 21Shin Nippon Biomedical Laboratories, Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 10Shin Nippon Biomedical Laboratories (TSE:2395) Is Due To Pay A Dividend Of ¥30.00
Mar 12Shin Nippon Biomedical Laboratories (TSE:2395) Has Affirmed Its Dividend Of ¥30.00
Feb 27Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 2395 has been paying a dividend for less than 10 years.
Growing Dividend: 2395's dividend payments have increased, but the company has only paid a dividend for 6 years.
Dividend Yield vs Market
| Shin Nippon Biomedical Laboratories Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (2395) | 3.6% |
| Market Bottom 25% (JP) | 1.9% |
| Market Top 25% (JP) | 4.0% |
| Industry Average (Life Sciences) | 3.0% |
| Analyst forecast (2395) (up to 3 years) | 4.4% |
Notable Dividend: 2395's dividend (3.57%) is higher than the bottom 25% of dividend payers in the JP market (1.9%).
High Dividend: 2395's dividend (3.57%) is low compared to the top 25% of dividend payers in the JP market (4.03%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (42.3%), 2395's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 2395 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/18 08:48 |
| End of Day Share Price | 2025/06/18 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shin Nippon Biomedical Laboratories, Ltd. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yuki Tsukamoto | BofA Global Research |
| Akitada Iwasa | Daiwa Securities Co. Ltd. |
| Stephen Barker | Jefferies LLC |